The diabetic patients in the country have good news which can save their monthly medicine bills. Over 15-20 companies are launching generic versions of the widely-prescribed anti-diabetic drug Vildagliptin, with its price expected to crash by half. The potential of more affordable diabetic care came in the wake of Swiss major Novartis-owned Vildagliptin losing patent […]
The government’s proposal to cap trade margins for all medicines outside price control at 30% has been agreed by the domestic drug industries and trade. This move will reduce the prices of nearly 80% of formulations. The drug pricing regulator, pharma lobby groups and industry associations have reached in an agreement regarding the price control […]
Highlighting that India’s copycat drug sector is still plagued by quality issues amid rising global concern over tainted drug supplies, U.S. health care watchdog FDA has sent warning letters to three major Indian drugmakers in the last two months. According to the reports, three major Indian drugmakers – Cadila Healthcare, Glenmark Pharmaceuticals and Lupin are […]